Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix Sells Anatrace Unit to Investment Firm StoneCalibre

Premium

StoneCalibre, a Los Angeles-based private investment firm, announced this week that it has acquired Affymetrix's Anatrace business unit. Financial details of the deal were not disclosed.

Anatrace develops, manufactures, and distributes detergents and synthetic lipids for use in membrane protein studies. Affymetrix gained the Maumee, Ohio-based business through its 2008 acquisition of reagents company USB (BAN 2/12/2008). The business has been maintained as part of Affymetrix's larger life science reagents unit, which generated $8 million in second quarter revenues and has been growing in the low single digits (BAN 8/6/2013).

According to StoneBridge, Anatrace will now become a standalone company. The firm tapped Ben Travis, who had been Affymetrix's life science reagents R&D director since 2005, to serve as CEO and president of the new company.

StoneCalibre CEO Brian Wall said in a statement that the investment company believes that under his firm's ownership Anatrace will "continue to build on its tradition of collaborating with its global customer base to help answer critical questions in the advancement of important studies across multiple scientific fields including cancer research."

StoneCalibre was founded last year. The company in June acquired Source Technologies, a Charlotte, NC-based provider of magnetic ink character recognition laser printers, consumables, maintenance, software, and accessories targeted primarily to the banking industry.

The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.